Product name: Anti-CD25/IL-2RA (Imterleukm-2 Receptor alpha)
Description: CD25 is the alpha alternation of the IL-2 receptor [1]. It is a blazon I transmembrane protein present on activated T cells, activated B cells, some thymocytes, myeloid precursors, and oligodendrocytes that assembly with CD122 to anatomy a heterodimer that can act as a high-affinity receptor for IL-2.
CD25 is bidding in a lot of B-cell neoplasms, some astute nonlymphocytic leukemias, neuroblastomas, and bump entering lymphocytes. Its acrid form, alleged sIL-2R may be animated in these diseases and is occasionally acclimated to clue ache progression.
Grauer et al. Approved a time-dependent accession of CD4 + FoxP3 + Tregs in academician tumors with a syngeneic murine glioma GL261 model. They empiric that the announcement of CD25.
More about:Anti-CD25/IL-2RA(Imterleukm-2 Receptor alpha) sales
From:Cytokines products
No comments:
Post a Comment